Can-Fite BioPharma (CANF) Total Debt (2014)
Can-Fite BioPharma (CANF) posted Total Debt of $21.2 million for Q4 2014.
Analysis
Can-Fite BioPharma (CANF) Total Debt (2014) Analysis & Trends
Can-Fite BioPharma (CANF) has 1 years of Total Debt data on file, last reported at $21.2 million in Q4 2014.
- For the quarter ending Q4 2014, Total Debt changed N/A year-over-year to $21.2 million; the trailing twelve-month figure through Dec 2014 stood at $21.2 million (changed N/A YoY), and the FY2014 full-year result was $21.2 million, changed N/A from the prior year.
- Total Debt was $21.2 million for Q4 2014 at Can-Fite BioPharma.
- In the past five years, Total Debt ranged from a high of $21.2 million in Q4 2014 to a low of $21.2 million in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | - |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - | - |